In addition, positive correlations between pretreatment serum CCL20 concentration and overall tumor stage and between posttreatment serum CCL20 concentration and indicators such as recurrence and metastasis rates were found in a prospective cohort (6). The gene discussed is CCL20; the disease is neoplasm.